Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 38 (RPS26P38) is a human processed pseudogene related to the functional RPS26 gene, which encodes a component of the 40S ribosomal subunit. Pseudogenes like RPS26P38 are non-functional remnants of genes, do not produce protein, and are not associated with known biological functions or disease mechanisms[4]. Therefore, RPS26P38 is not considered a therapeutic target, does not have known clinical relevance, and is excluded from most structured drug targeting databases. Functional ribosomal protein S26 (RPS26) has biological significance as a core ribosomal protein but is distinct from its processed pseudogenes[1][2]. RPS26 pseudogenes, including RPS26P38, are scattered throughout the human genome and do not participate in protein synthesis or cellular pathways[2][4]. If your goal is to find information about a functional ribosomal protein (such as RPS26), that would be a different entity with biological importance; however, RPS26P38 is *not* a biologically active protein, enzyme, or receptor, nor a target for therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 38 (RPS26P38).